{"version":"1.0","provider_name":"Humanitas.net","provider_url":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/","author_name":"Emicha","author_url":"https:\/\/humanitas-net.humweb.webiz.team\/ro\/author\/emicha\/","title":"Milrinon\u0103 - Humanitas.net","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"0DcAoBa7mc\"><a href=\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wiki\/milrinona\/\">Milrinon\u0103<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/humanitas-net.humweb.webiz.team\/ro\/wiki\/milrinona\/embed\/#?secret=0DcAoBa7mc\" width=\"600\" height=\"338\" title=\"&#8220;Milrinon\u0103&#8221; &#8212; Humanitas.net\" data-secret=\"0DcAoBa7mc\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/humanitas-net.humweb.webiz.team\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Milrinona este utilizat\u0103 pentru a trata insuficien\u021ba cardiac\u0103 congestiv\u0103, o afec\u021biune caracterizat\u0103 de staz\u0103 venoas\u0103 \u0219i un flux redus de s\u00e2nge din ventriculul st\u00e2ng, cauz\u00e2nd simptome precum astenie, dispnee, edem \u0219i disconfort abdominal. Din cauza efectelor toxice pe care le poate prezenta, acest medicament nu este administrat, de obicei, pentru mai mult de 48 de [&hellip;]"}